These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38864837)

  • 21. Utilizing machine learning techniques to predict the blood-brain barrier permeability of compounds detected using LCQTOF-MS in Malaysian Kelulut honey.
    Edros R; Feng TW; Dong RH
    SAR QSAR Environ Res; 2023; 34(6):475-500. PubMed ID: 37409842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the Pfizer Central Nervous System Multiparameter Optimization Calculator and a BBB Machine Learning Model.
    Urbina F; Zorn KM; Brunner D; Ekins S
    ACS Chem Neurosci; 2021 Jun; 12(12):2247-2253. PubMed ID: 34028255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ensemble modeling with machine learning and deep learning to provide interpretable generalized rules for classifying CNS drugs with high prediction power.
    Yu TH; Su BH; Battalora LC; Liu S; Tseng YJ
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34530437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A machine learning-based quantitative model (LogBB_Pred) to predict the blood-brain barrier permeability (logBB value) of drug compounds.
    Shaker B; Lee J; Lee Y; Yu MS; Lee HM; Lee E; Kang HC; Oh KS; Kim HW; Na D
    Bioinformatics; 2023 Oct; 39(10):. PubMed ID: 37713469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-animal models for blood-brain barrier permeability evaluation of drug-like compounds.
    Dehnbostel FO; Dixit VA; Preissner R; Banerjee P
    Sci Rep; 2024 Apr; 14(1):8908. PubMed ID: 38632344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Central Nervous System Side Effects Through Drug Permeability to Blood-Brain Barrier and Recommendation Algorithm.
    Fan J; Yang J; Jiang Z
    J Comput Biol; 2018 Apr; 25(4):435-443. PubMed ID: 29058464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning.
    Miao R; Xia LY; Chen HH; Huang HH; Liang Y
    Sci Rep; 2019 Jun; 9(1):8802. PubMed ID: 31217424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR modeling of the blood-brain barrier permeability for diverse organic compounds.
    Zhang L; Zhu H; Oprea TI; Golbraikh A; Tropsha A
    Pharm Res; 2008 Aug; 25(8):1902-14. PubMed ID: 18553217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors.
    Meng F; Xi Y; Huang J; Ayers PW
    Sci Data; 2021 Oct; 8(1):289. PubMed ID: 34716354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications.
    Gao Z; Chen Y; Cai X; Xu R
    Bioinformatics; 2017 Mar; 33(6):901-908. PubMed ID: 27993785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
    Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes.
    Zhao YH; Abraham MH; Ibrahim A; Fish PV; Cole S; Lewis ML; de Groot MJ; Reynolds DP
    J Chem Inf Model; 2007; 47(1):170-5. PubMed ID: 17238262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Recurrent Neural Network model to predict blood-brain barrier permeability.
    Alsenan S; Al-Turaiki I; Hafez A
    Comput Biol Chem; 2020 Dec; 89():107377. PubMed ID: 33010784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finding Needles in a Haystack: Determining Key Molecular Descriptors Associated with the Blood-brain Barrier Entry of Chemical Compounds Using Machine Learning.
    Majumdar S; Basak SC; Lungu CN; Diudea MV; Grunwald GD
    Mol Inform; 2019 Aug; 38(8-9):e1800164. PubMed ID: 31322827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods.
    Li H; Yap CW; Ung CY; Xue Y; Cao ZW; Chen YZ
    J Chem Inf Model; 2005; 45(5):1376-84. PubMed ID: 16180914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Simple Method to Predict Blood-Brain Barrier Permeability of Drug- Like Compounds Using Classification Trees.
    Castillo-Garit JA; Casanola-Martin GM; Le-Thi-Thu H; Pham-The H; Barigye SJ
    Med Chem; 2017; 13(7):664-669. PubMed ID: 28185535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New predictive models for blood-brain barrier permeability of drug-like molecules.
    Kortagere S; Chekmarev D; Welsh WJ; Ekins S
    Pharm Res; 2008 Aug; 25(8):1836-45. PubMed ID: 18415049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BBB-PEP-prediction: improved computational model for identification of blood-brain barrier peptides using blending position relative composition specific features and ensemble modeling.
    Naseem A; Alturise F; Alkhalifah T; Khan YD
    J Cheminform; 2023 Nov; 15(1):110. PubMed ID: 37980534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to approach machine learning-based prediction of drug/compound-target interactions.
    Atas Guvenilir H; Doğan T
    J Cheminform; 2023 Feb; 15(1):16. PubMed ID: 36747300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Blood-Brain Barrier (BBB) Score.
    Gupta M; Lee HJ; Barden CJ; Weaver DF
    J Med Chem; 2019 Nov; 62(21):9824-9836. PubMed ID: 31603678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.